Tus kws kho mob
P22-22 eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1011 - 1020 ntawm 4179
Tus kws kho mob
P23-22 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
P24-22 Update: eviCore Healthcare Specialty Utilization Management (UM) Program – Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Tus kws kho mob
2022 April Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Plaub Hlis Ntuj Tim 01, 2022
Cov Txiaj Ntsig thiab Kev Duav Roos
Blue Plus 2022 Formulary
Tus kws kho mob
QP54-22 Update for New to Market Medical Drugs: betibeglogene autotemcel
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 22, 2022
Tus kws kho mob
QP39-22 Required Notification of Medicare Organization Determination Request Dismissal and Withdrawal
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP46-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective July 28, 2022
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP47-22 Medical Drug Management Update – Alpha-1 Proteinase Inhibitors
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022
Tus kws kho mob
QP48-22 MHCP Pharmacy Benefit Exclusion for Korsuva™ and Leqvio®
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 08, 2022